Aastrom Biosciences (ASTM) says that president and CEO Tim Mayleben has decided to retire once...
Aastrom Biosciences (ASTM) says that president and CEO Tim Mayleben has decided to retire once the company has hired a successor. Mayleben will continue to serve as a member of the board of directors after the transition. The company notes that it's initiated a search for a new chief executive. Shares -0.6% AH.
From other sites
at MarketWatch.com (Jan 2, 2013)
at MarketWatch.com (Sep 6, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs